Medicinova Inc. Stock
Medicinova Inc. Stock
Medicinova Inc. is currently one of the favorites of our community with 8 Buy predictions and no Sell predictions.
With a target price of 7 € there is potential for a 117.53% increase which would mean more than doubling the current price of 3.22 € for Medicinova Inc..
Pros and Cons of Medicinova Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medicinova Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medicinova Inc. | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | -0.410% | 1.801% | -17.320% | -57.946% | -36.580% | -71.740% | -95.128% |
| Evolus Inc | -1.110% | 4.046% | -22.078% | -56.098% | -33.945% | -51.351% | -67.857% |
| Sangamo Therapeutics Inc. | 1.000% | -15.717% | -37.386% | -65.319% | -36.993% | -83.471% | -97.618% |
Comments
MediciNova (MNOV) had its "buy" rating reaffirmed by Maxim Group. They now have a $6.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat
MediciNova (MNOV) is now covered by HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat
MediciNova (NASDAQ:MNOV) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat